• JB Hi-Fi, GPT Group, Charter Hall shares hit 52-week low: Is there any chance of a rebound?

    Stressed businessman sits in panic amid digital stock market financial background.

    JB Hi-Fi Ltd (ASX: JBH), GPT Group Ltd (ASX: GPT), and Charter Hall Group (ASX: CHC) shares have tumbled to an annual low in Thursday lunchtime trade as the S&P/ASX 200 Index (ASX: XJO) comes under more pressure.

    Here’s what has happened, and what brokers tip next.

    Charter Hall shares

    The diversified property funds manager’s shares have fallen 2% to an annual low of $18.03 at the time of writing. The latest decline means the shares have now crashed 24% over the past month and they’re 27% lower for the year-to-date.

    There hasn’t been any price sensitive announcement out of the company this week. Instead it looks like it has been hit by a series of headwinds, including higher-than-expected inflation figures and a weakening property market. Concerns about further interest rate hikes are also putting pressure on property-related stocks across the sector.

    Even the company’s robust FY26 result announcement late last month didn’t do enough to reignite investor confidence. Management announced a 26.8% increase in operating earnings, gross property transactions of $17.1 billion and the launch of multiple new funds and partnerships.

    The experts are still bullish that there will be some upside ahead. Market Index data shows that the majority have a strong buy rating on Charter Hall shares. The $24.14 average target price implies around a 33% upside ahead, at the time of writing.

    GPT Group shares

    As one of Australia’s largest listed property trusts, GPT is facing the same headwinds as Charter Hall shares this week.

    The company, which owns and manages a portfolio of Australian office, logistics, and retail assets, with funds under management of more than $36 billion, is highly sensitive to shifts in property market sentiment.

    Its shares are also down around 2% today, to an annual low of $4.41 each. Over the past month the shares have crashed 16%, and they’re now 20% lower for the year-to-date.

    The company also posted a solid first-half FY26 result last month, including a statutory net profit after tax of $400.1 million for the half year, and a reported investment portfolio occupancy of 97.6%.

    Experts are also bullish about the share price outlook over the next 12 months. Market Index data shows the majority have a strong buy rating on GPT Group shares, and the $5.33 average target price implies an upside of around 19%, at the time of writing,

    JB Hi-Fi shares

    JB Hi-Fi shares are also down around 2% in Thursday lunchtime trade, and changing hands at a two-year low of $64.70 at the time of writing. Over the past month, the shares have fallen 23%, and they’re 33% lower year-to-date.

    Consumer discretionary stocks like JB Hi-Fi have come under pressure recently amid market concerns about higher interest rates, inflation, and weaker consumer confidence.

    And it looks like the company’s FY26 results in late August further dampened confidence. Management posted record revenue of $11.06 billion, up 4.8% from FY25. Meanwhile, EBIT increased 5.8% to $734.4 million. On the bottom line, the company reported a net profit after tax (NPAT) of $489.9 million, up 6% year-on-year. After delivering higher profit, management declared a final fully franked dividend of $1.27 per share.

    But looking ahead, JB Hi-Fi said it expects a variable trading environment in the short term but notes ongoing resilience among its brands and flagged that the company saw a slight dip in sales in July. 

    Investors were clearly spooked, and analysts also seem on the fence about the share price outlook. Market Index data shows broker ratings are split between a buy and a hold. However, after the latest selloff, the $79.34 average target price now implies 21% potential upside.

    The post JB Hi-Fi, GPT Group, Charter Hall shares hit 52-week low: Is there any chance of a rebound? appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Charter Hall Group right now?

    Before you buy Charter Hall Group shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Charter Hall Group wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Buy, hold, sell: Select Harvests, Seek, SKS Technologies shares

    A middle-aged man working from home looks at his mobile phone with a laptop open on the table in front of him.

    S&P/ASX All Ords Index (ASX: XAO) shares are down 1.5% at 8,963 points on Thursday.

    Meanwhile, three experts give us their views on three ASX All Ords shares on The Bull.

    Let’s review. 

    SKS Technologies Group Ltd (ASX: SKS)

    The SKS Technologies share price is $7.89, down 1.9% today but up 155% over 12 months.

    Mark Elzayed from Vestra Capital has a buy rating on this ASX 200 industrials share. 

    Elzayed said: 

    SKS Technologies has established a significant market footprint in electrical, fibre optic and audiovisual integration for major data centre projects.

    The company generated revenue of $347.93 million in full year 2026, up 33 per cent on the prior corresponding period. Net profit after tax of $27.11 million surged 93.2 per cent. Data centre revenue of $207.7 million was up 47.6 per cent year on year.

    The balance sheet is also stronger, with cash from operations increasing 30.5 per cent.

    The primary catalyst for SKS is its accelerating work on hand and structural exposure to Australia’s expanding data centre market.

    In my view, SKS represents a high conviction growth opportunity, supported by strong demand visibility and a substantial project pipeline.

    Select Harvests Ltd (ASX: SHV)

    The Select Harvests share price is $4.56, down 2.4% today and up 26% over 12 months. 

    Select Harvests is the world’s No. 5 almond producer.

    Elzayed has a sell rating on this ASX agriculture share.

    The broker said: 

    Risks include its exposure to seasonal weather volatility and intense international competition, particularly from large US and Californian almond producers.

    Earnings remain exposed to agricultural yields, almond pricing and input cost volatility.

    Given the stock’s relatively modest performance compared with higher growth industrial and technology opportunities, the risk-reward profile isn’t as attractive.

    We would be inclined to cash in some gains after a solid share price performance since mid May.

    Seek Ltd (ASX: SEK)

    The Seek share price is $12.69, down 0.9% today and down 53% over 12 months. 

    Blake Halligan from Gray Perry Wealth Advisers has a buy rating on this ASX 200 communications share. 

    Halligan said: 

    Seek operates a leading online employment marketplace, with a dominant position in Australia and established operations across Asia.

    Its scalable model, strong margins and international expansion provide attractive long-term growth potential.

    Despite softer job-ad volumes, fiscal year 2026 net revenue rose 10 per cent and EBITDA increased 15 per cent, demonstrating pricing power and operational resilience.

    We’re forecasting earnings to grow about 9.5 per cent annually in the next two years.

    An improving return on equity and a healthy dividend further support the investment case.

    The post Buy, hold, sell: Select Harvests, Seek, SKS Technologies shares appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Sks Technologies Group right now?

    Before you buy Sks Technologies Group shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Sks Technologies Group wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Sks Technologies Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Buy, hold, sell: Generation Development, Fletcher Building, Saluda Medical shares

    A young man working from home sits at his home office desk holding a cup of tea and looking out the window.

    S&P/ASX All Ords Index (ASX: XAO) shares are down 1.6% to 8,961.6 points on Thursday.

    Meanwhile, on The Bull, three experts give us their views on three ASX All Ords shares.

    Let’s check them out. 

    Saluda Medical Inc (ASX: SLD)

    The Saluda Medical share price is 40 cents, down 3.7% today and down 69% over 12 months. 

    Stuart Bromley from Medallion Financial Group has a buy call on this ASX All Ords healthcare share

    Bromley said: 

    Saluda makes the Evoke spinal cord stimulator, which automatically adjusts pain therapy in real time.

    Results in full year 2026 were strong, in our view. Revenue of $US90.2 million was up 28 per cent on the prior corresponding period and ahead of upgraded guidance. US patient implants increased by 50 per cent in the fourth quarter of 2026.

    With its newly approved CAP24 surgical paddle lead expanding the addressable US market by about 30 per cent, we believe SLD presents as an attractive buying opportunity for investors comfortable with potential share price volatility and risk.

    Generation Development Group Ltd (ASX: GDG)

    The Generation Development share price is $3.12, down 2.5% today and down 51% over 12 months. 

    Bromley has a hold rating on this ASX 200 financial share.  

    He said: 

    GDG operates a portfolio of growing financial services businesses, including Generation Life, Evidentia Group and Lonsec.

    Total revenue of $178.7 million in full year 2026 was up 23 per cent on the prior corresponding period.

    Underlying net profit after tax of $40.7 million grew 21 per cent, supported by growth of 37 per cent in funds under management and record group net inflows of $9.7 billion.

    We believe GDG’s longer term growth opportunity remains intact.

    Fletcher Building Ltd (ASX: FBU)

    The Fletcher Building share price is $3.04, down 2.3% today and up 9% over 12 months. 

    Mark Elzayed from Vestra Capital has a sell rating on this ASX 200 industrials share. 

    Elzayed said: 

    The return to profitability reflected a combination of cost reductions, portfolio simplification, property sale gains and an improved performance across several core manufacturing businesses, rather than a broad based recovery in underlying construction demand.

    Revenue of $NZ5.994 billion from continuing operations increased 7.3 per cent in full year 2026 when compared to the prior corresponding period.

    Total net earnings attributable to shareholders reached $NZ228 million, compared to a loss of $NZ419 million in the prior year.

    The return to profitability improves the balance sheet and reduces financial risk. But, in my view, a continuing recovery remains heavily dependent on building markets returning to normal in what I consider a most challenging underlying environment.

    The post Buy, hold, sell: Generation Development, Fletcher Building, Saluda Medical shares appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Saluda Medical right now?

    Before you buy Saluda Medical shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Saluda Medical wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Generation Development Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Sorry, but nothing was found. Please try a search with different keywords.